Effectiveness of Infiltrations in the Treatment of Plantar Fasciopathy

Inclusion Criteria: Age: Participants aged 18 to 50 years. Diagnosis: Confirmed diagnosis of plantar fasciopathy based on clinical evaluation and imaging (if applicable). Duration of Symptoms: Symptoms persisting for at least 6 weeks prior to enrollment. Pain Level: Reported pain level of at least 4 on the Visual Analog Scale (VAS) at baseline. Ability to Comply: Participants must be able to follow study protocols and attend follow-up appointments. Informed Consent: Participants must provide written informed consent to participate in the study. Exclusion Criteria: Other Foot Pathologies: Presence of other significant foot conditions (e.g., fractures, arthritis, tarsal tunnel syndrome) that could interfere with the study results. Pregnancy or Breastfeeding: Pregnant or breastfeeding individuals will be excluded from the study. Neurological Disorders: History of significant neurological disorders affecting lower limb function. Systemic Conditions: Patients with systemic conditions (e.g., diabetes, autoimmune diseases) that could affect healing or response to treatment. Allergy to Corticosteroids: Known allergy or adverse reaction to corticosteroids or local anesthetics. Psychiatric Disorders: Individuals with severe psychiatric disorders that may impair their ability to provide informed consent or adhere to the study protocol.